Chemotherapy Current Events | Chemotherapy News | 9
|
| Page
9 of
25 |
498 Results |
|
|
|
Sort By:
Page Views | Date |
OHSU Cancer Institute researchers find many stomach cancer patients are not gertting best therapy
New findings from Oregon Health & Science University Cancer Institute show significant numbers of patients nationwide who are not getting the recommended therapy after surgery to remove stomach cancer. view more (2008-05-30)
Protein found to protect breast cancer tumors from chemotherapy
About half of women whose breast cancer is treated with standard chemotherapy have their cancer return within five years. Most chemotherapeutic drugs have undesirable side effects, but there has been no way to predict who would benefit and who wouldn't. view more (2006-08-22)
Drug that chokes off tumor blood vessels offers new hope to lung cancer patients
Patients suffering from the most common type of lung cancer experienced a 20-percent improvement in overall survival in a national clinical trial of a drug that chokes off the blood vessels nourishing tumors, a multicenter study has found. view more (2006-12-14)
New treatment more than doubles survival for high risk childhood leukemia
Results of a phase two clinical trial published October 5th in the Journal of Clinical Oncology show that adding continuous daily doses of a targeted drug called imatinib mesylate to regular chemotherapy more than doubled three-year survival rates for children with a high risk type of blood cancer called Philadelphia chromosome-positive acute... view more... (2009-10-07)
Nanoparticle 'Smart Bomb' Targets Drug Delivery to Cancer Cells
Researchers at North Carolina State University have successfully modified a common plant virus to deliver drugs only to specific cells inside the human body, without affecting surrounding tissue. view more (2009-02-13)
MRI drug may improve cancer-killing ability of chemotherapy, study says
A contrast agent currently used in magnetic resonance imaging (MRI), called mangafodipir, may increase the cancer-killing ability of some chemotherapy drugs while protecting normal cells. view more (2006-02-15)
A search for protection against chemotherapy cardiotoxicity
Researchers at the University of Grenoble, in France, have discovered that erythropoietin administration prevents acute cardiotoxic effects induced by doxorubicin and trastuzumab exposures. view more (2007-12-21)
Genomic signatures identify targeted therapies for lung cancer
Any number of things can go wrong in the cells of the body to cause cancer -- and clinicians can't tell by just looking at a tumor what exactly triggered the once normal cells to turn cancerous. view more (2007-06-04)
'Corrective genes' closer thanks to enzyme modification
Scientists from the Université de Montréal and McGill University have re-engineered a human enzyme, a protein that accelerates chemical reactions within the human body, to become highly resistant to harmful agents such as chemotherapy, according to a new study published in The Journal of Biological Chemistry. view more (2009-07-29)
Experimental Drug Boosts Survival in Recurrent Ovarian Cancer Patients
New clinical data showed an experimental drug called pertuzumab prolonged the survival time for women with recurrent ovarian cancer, a University of Alabama at Birmingham doctor said recently. view more (2007-09-28)
USC researchers show that molecular markers predict tumor recurrence
Researchers at the University of Southern California (USC) have identified specific molecular markers that may help to predict tumor recurrence in stage II and III colon cancer patients. view more (2007-06-06)
Lean muscle mass helps even obese patients battle cancer
Lean muscle-mass may give even obese people an advantage in battling cancer, a University of Alberta study shows. view more (2008-12-18)
Potential diagnostic marker indicates effectiveness of anti-angiogenic drugs
If an anti-angiogenic drug is successfully starving a cancer patient's tumor to death, the number of endothelial cells circulating in the individual's bloodstream will decrease, thus providing a potential biomarker for gauging the medication's effectiveness. view more (2006-09-18)
Rapid restoration of immunity in immune-suppressed cancer patients using T-cell vaccines
Patients with multiple myeloma suffer from a malignant proliferation of plasma cells in their bone marrow. view more (2005-10-21)
Mass. General study finds potential ovarian cancer stem cells
Massachusetts General Hospital (MGH) researchers have identified potential ovarian cancer stem cells, which may be behind the difficulty of treating these tumors with standard chemotherapy. view more (2006-07-24)
New genomic tests guide choice of chemotherapy in cancer patients
Scientists at Duke University's Institute for Genome Sciences & Policy have developed a panel of genomic tests that analyzes the unique molecular traits of a cancerous tumor and determines which chemotherapy will most aggressively attack that patient's cancer. view more (2006-10-23)
Testicular cancer patients may be more at risk from the treatment than the cancer returning
Testicular cancer - cure rates now so high patients may be more at risk from the treatment than the cancer returning say researchers view more (2002-02-23)
Targeted heat therapy offers new standard treatment option for soft tissue sarcoma
Patients with soft-tissue sarcomas at high risk of spreading were 30% more likely to be alive and cancer free almost three years after starting treatment if their tumours were heated at the time they received chemotherapy, according to new research. view more (2009-09-22)
Experimental chemotherapy regimen shows promise in treating advanced lung cancer
A combination of chemotherapy agents that have been tested in other tumor types appears to be a promising alternative to standard treatment for advanced non-small cell lung cancer, according to a report in the August 15 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research. view more (2008-08-12)
Chemotherapy-induced anemia increases risk of local breast cancer recurrence
Patients with breast cancer who developed anemia during chemotherapy had nearly three times the risk of local recurrence as those who did not, according to a study published in the April 1 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research. view more (2008-04-01)
|
|
| Page
9 of
25 |
498 Results |
|
|
|
Sort By:
Page Views | Date |
|
